메뉴 건너뛰기




Volumn 56, Issue 20, 2013, Pages 8089-8103

Selective arylsulfonamide inhibitors of ADAM-17: Hit optimization and activity in ovarian cancer cell models

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 ((5 BROMO 4' METHOXYBIPHENYL 3 YL)METHOXY)PHENYLSULFONAMIDO] N HYDROXYACETAMIDE; 2 [4 (3 BROMOBENZYLOXY)PHENYLSULFONAMIDO] N HYDROXYACETAMIDE; 2 [4 (3 FLUOROBENZYLOXY)PHENYLSULFONAMIDO] N HYDROXYACETAMIDE; 2 [4 (3,5 DIBROMOBENZYLOXY) N METHYLPHENYLSULFONAMIDO] N HYDROXYACETAMIDE; 2 [4 (3,5 DIBROMOBENZYLOXY)PHENYLSULFONAMIDO] N HYDROXY 5 UREIDOPENTANAMIDE; 2 [4 (3,5 DIFLUOROBENZYLOXY)PHENYLSULFONAMIDO] N HYDROXYACETAMIDE; 2 [4 (4 BROMOBENZYLOXY)PHENYLSULFONAMIDO] N HYDROXYACETAMIDE; 2 [4 (4 FLUOROBENZYLOXY)PHENYLSULFONAMIDO] N HYDROXYACETAMIDE; 2 [4 (BIPHENYL 3 YLMETHOXY)PHENYLSULFONAMIDO] N HYDROXYACETAMIDE; 3 [3 BROMO 5 ((4 (N (2 (HYDROXYAMINO) 2 OXOETHYL)SULFAMOYL)PHENOXY)METHYL)PHENYL]PYRIDINIUM 2,2,2 TRIFLUOROACETATE; ANTINEOPLASTIC AGENT; BENZYL 3 [4 (3,5 DIBROMOBENZYLOXY)PHENYLSULFONAMIDO] 4 (HYDROXYAMINO0 4 OXOPETYLCARBAMATE; BENZYL 4 [4 (3,5 DIBROMOBENZYLOXY)PHENYLSULFONAMIDO] 5 (HYDROXYAMINO) 5 OXOPETYLCARBAMATE; N HYDROXY 2 [4 (3 (TRIFLUOROMETHOXY)BENZOYLOXY) PHENYLSULFONAMIDO]ACETAMIDE; N HYDROXY 2 [4 (4 (TRIFLUOROMETHOXY)BENZOYLOXY) PHENYLSULFONAMIDO]ACETAMIDE; N HYDROXY 2 [4 (QUINOLIN 8 YLMETHOXY)PHENYLSULFONAMIDO]ACETAMIDE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR; UNCLASSIFIED DRUG;

EID: 84886567237     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm4011753     Document Type: Article
Times cited : (24)

References (36)
  • 4
    • 34247236142 scopus 로고    scopus 로고
    • Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors
    • Santiago-Josefat, B.; Esselens, C.; Bech-Serra, J. J.; Arribas, J. Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors J. Biol. Chem. 2007, 282, 8325-8331
    • (2007) J. Biol. Chem. , vol.282 , pp. 8325-8331
    • Santiago-Josefat, B.1    Esselens, C.2    Bech-Serra, J.J.3    Arribas, J.4
  • 5
    • 36048938454 scopus 로고    scopus 로고
    • TACE: A new target in epidermal growth factor receptor dependent tumors
    • Kenny, P. A. TACE: a new target in epidermal growth factor receptor dependent tumors Differentiation 2007, 75, 800-808
    • (2007) Differentiation , vol.75 , pp. 800-808
    • Kenny, P.A.1
  • 9
    • 77949834395 scopus 로고    scopus 로고
    • ADAMs and ADAMTs Selective Synthetic Inhibitors
    • Supuran, C. T. Winum, J.-Y. Wiley Series in Drug Discovery and Development; John Wiley & Sons: Hoboken, NJ
    • Rossello, A.; Nuti, E.; Maresca, A. ADAMs and ADAMTs Selective Synthetic Inhibitors. In Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications; Supuran, C. T.; Winum, J.-Y., Eds.; Wiley Series in Drug Discovery and Development; John Wiley & Sons: Hoboken, NJ, 2009; pp 591-645.
    • (2009) Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications , pp. 591-645
    • Rossello, A.1    Nuti, E.2    Maresca, A.3
  • 10
    • 33646584823 scopus 로고    scopus 로고
    • Recent advances in MMP inhibitor design
    • Fisher, J. F.; Mobashery, S. Recent advances in MMP inhibitor design Cancer Metastasis Rev. 2006, 25, 115-136
    • (2006) Cancer Metastasis Rev. , vol.25 , pp. 115-136
    • Fisher, J.F.1    Mobashery, S.2
  • 11
    • 52949136266 scopus 로고    scopus 로고
    • Specific targeting of metzincin family members with small-molecule inhibitors: Progress toward a multifarious challenge
    • Georgiadis, D.; Yiotakis, A. Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge Bioorg. Med. Chem. 2008, 16, 8781-8794
    • (2008) Bioorg. Med. Chem. , vol.16 , pp. 8781-8794
    • Georgiadis, D.1    Yiotakis, A.2
  • 20
    • 2142828483 scopus 로고    scopus 로고
    • Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme
    • Neumann, U.; Kubota, H.; Frei, K.; Ganu, V.; Leppert, D. Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme Anal. Biochem. 2004, 328, 166-173
    • (2004) Anal. Biochem. , vol.328 , pp. 166-173
    • Neumann, U.1    Kubota, H.2    Frei, K.3    Ganu, V.4    Leppert, D.5
  • 22
    • 73249123318 scopus 로고    scopus 로고
    • Evolutionary divergence and functions of the ADAM and ADAMTS gene families
    • Brocker, C. N.; Vasiliou, V.; Nebert, D. W. Evolutionary divergence and functions of the ADAM and ADAMTS gene families Hum. Genomics 2009, 4, 43-55
    • (2009) Hum. Genomics , vol.4 , pp. 43-55
    • Brocker, C.N.1    Vasiliou, V.2    Nebert, D.W.3
  • 23
    • 33745477470 scopus 로고    scopus 로고
    • Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis
    • Bech-Serra, J. J.; Santiago-Josefat, B.; Esselens, C.; Saftig, P.; Baselga, J.; Arribas, J.; Canals, F. Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis Mol. Cell. Biol. 2006, 26, 5086-5095
    • (2006) Mol. Cell. Biol. , vol.26 , pp. 5086-5095
    • Bech-Serra, J.J.1    Santiago-Josefat, B.2    Esselens, C.3    Saftig, P.4    Baselga, J.5    Arribas, J.6    Canals, F.7
  • 26
    • 84886549647 scopus 로고    scopus 로고
    • version 5.5; Schrödinger, LLC: New York.
    • Glide, version 5.5; Schrödinger, LLC: New York, 2009.
    • (2009) Glide
  • 28
    • 77954827231 scopus 로고    scopus 로고
    • The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function
    • Grossman, M.; Tworowski, D.; Dym, O.; Lee, M. H.; Levy, Y.; Murphy, G.; Sagi, I. The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function Biochemistry 2010, 49, 6184-6192
    • (2010) Biochemistry , vol.49 , pp. 6184-6192
    • Grossman, M.1    Tworowski, D.2    Dym, O.3    Lee, M.H.4    Levy, Y.5    Murphy, G.6    Sagi, I.7
  • 29
    • 80052993945 scopus 로고    scopus 로고
    • Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor
    • Hashimoto, H.; Takeuchi, T.; Komatsu, K.; Miyazaki, K.; Sato, M.; Higashi, S. Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor J. Biol. Chem. 2011, 286, 33236-33243
    • (2011) J. Biol. Chem. , vol.286 , pp. 33236-33243
    • Hashimoto, H.1    Takeuchi, T.2    Komatsu, K.3    Miyazaki, K.4    Sato, M.5    Higashi, S.6
  • 31
    • 84886541872 scopus 로고    scopus 로고
    • version 4.7.1; Molecular Devices: Sunnyvale, CA.
    • SoftMax Pro, version 4.7.1; Molecular Devices: Sunnyvale, CA.
    • SoftMax Pro
  • 32
    • 84886485407 scopus 로고    scopus 로고
    • version 4; Erithecus Software: West Sussex, U.K.
    • GraFit, version 4; Erithecus Software: West Sussex, U.K.
    • GraFit
  • 33
    • 84886530345 scopus 로고    scopus 로고
    • version 9.1; Schrödinger, LLC: New York.
    • Maestro, version 9.1; Schrödinger, LLC: New York, 2009.
    • (2009) Maestro


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.